Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dasatinib + Chemotherapy in Pediatric Ph+ ALL
NCT01460160Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Apr 2012
- Primary completion
- May 2017
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
- Countries
- 6
01
Overview
A Phase 2 trial of dasatinib in Acute lymphoblastic leukemia, Philadelphia chromosome positive, sponsored by Bristol Myers Squibb. Started Apr 2012; status: completed.
02
Drugs
dasatinib
03
Conditions
Acute lymphoblastic leukemia, Philadelphia chromosome positive
Beyond the preview
Go deeper on NCT01460160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01460160.